Lisa Larrimore Ouellette, the Deane F. Johnson Professor of Law at Stanford Law School, has been appointed to a committee within the National Academies of Sciences, Engineering, and Medicine. The committee, established in March 2024, is tasked with examining how investments in innovative therapeutic developments align with actual disease burdens and unmet medical needs. It aims to propose strategies to enhance innovation, particularly to address health disparities and unmet needs in therapeutic development.
Ouellette’s appointment is part of a larger initiative by the National Academies to improve the alignment between medical innovation and public health necessities. The committee will evaluate current patterns in the development of novel therapies and recommend measures to spur innovation in areas that are currently underserved. For more details, you can read the full announcement here.